AIBOTICS, INC.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Aibotics
Medicinal Chemicals & Botanical Products, SIC 2833
Aibotics, Inc. develops wellness and healthcare technologies, focusing on consumer robotics and the research of psychedelics for mental health treatments. The company's consumer product offerings include the Phill Robot, an artificial-intelligence-controlled massage robot designed for home use, and Milkyway, an automated smart storage refrigerator designed for preserving breast milk. In its therapeutic activities, the company promotes studies on natural and synthetic molecules to treat conditions like depression and addiction, while sourcing naturally derived psilocybin active pharmaceutical ingredients. Its target customers and partners include retail consumers, nursing rooms, hospitals, research institutions, universities, and pharmaceutical manufacturers.
The company operates virtually without owning physical real estate or leasing office facilities. Its corporate headquarters or specific physical operational facilities are not specified in the text, as it conducts business through a fully remote model. While aiming to supply active pharmaceutical ingredients to international jurisdictions that permit psilocybin, the company presently operates with a single subsidiary in Florida.
Summary of the business section of Aibotics's latest annual report, written by StockData.
Company profile
Company
- Legal name
- AIBOTICS, INC.
- Founded
- 2000
- Headquarters
- Heyburn, ID
- Address
- 480 22nd Street 83336
- Phone
- (208) 677-2020
- Employees
- 1, Dec 31, 2020
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- Fruci & Associates II, PLLC, Spokane, Washington
Stock & identifiers
- Ticker
- AIBT
- Exchange
- OTC
- Shares outstanding
- 850M, Aug 19, 2026
- Public float
- $1.37M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 2-for-1, May 1, 2014
- SEC CIK
- 1763329
- EIN
- 87-0645794
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Benjamin Nathaniel Kaplan | CEO, Director | 95,250,000 |
| Benjamin Kaplan | CEO, Director | 20,250,000 |
| Mark Croskery | Director | 10,016,912 |
Employees
Headcount reported in annual reports
“We currently have one employee, who is also our chief executive officer.”
Corporate history
Events identified from SEC filings